CSat Investment Advisory’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-872
Closed -$21K 668
2020
Q3
$21K Buy
872
+115
+15% +$2.69K ﹤0.01% 848
2020
Q2
$18K Sell
757
-2,479
-77% -$57.5K ﹤0.01% 859
2020
Q1
$56K Buy
3,236
+546
+20% +$9.99K 0.01% 494
2019
Q4
$47K Sell
2,690
-6,011
-69% -$102K 0.01% 633
2019
Q3
$154K Buy
8,701
+1,526
+21% +$30.9K 0.05% 248
2019
Q2
$153K Buy
+7,175
New +$150K 0.05% 223

Other funds holding EXEL

CSat Investment Advisory's EXEL Position: Q4 2020 in Review

CSat Investment Advisory sold out of Exelixis (EXEL) in Q4 2020, closing a stake of 872 shares — an estimated $21K sold.

CSat Investment Advisory first reported a position in EXEL in Q2 2019 and held it in 6 quarters. The position peaked at $154K in Q3 2019. 352 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

  • CSat Investment Advisory reported no remaining Exelixis position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 872 Exelixis shares in Q4 2020, an estimated $21K.
  • CSat Investment Advisory first reported a position in Exelixis in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Exelixis position peaked at $154K in Q3 2019.
  • 352 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.